Short Course: Coming Soon!
October 13-14: Conference
Co-Sponsored with Critical Path Institute’s eCOA Consortium
Members of the Electronic Clinical Outcome Assessment (eCOA) Consortium are firms that provide electronic data collection technologies and services for capturing COA data in clinical trials. The eCOA Consortium provides a pre-competitive environment in which a critical mass of experts can collaborate to generate measurement equivalence data, develop specification documents and data standards, and provide guidance on methodological considerations related to eCOA applications. All of these activities are aimed at enhancing the quality, practicality and acceptability of electronic capture of clinical trial endpoint data.
Digital technology is transforming the drug, device, and diagnostics development process. The rise of wearable and mobile technologies along with cloud technology, artificial intelligence and related platforms, now enable the collection and analysis of frequent, specific, and multidimensional data throughout the length of trials. These technologies have the potential to enable innovative trial designs, improve the patient experience, act as recruitment and retention tools, and establish novel end points in clinical studies.
What are the advantages and disadvantages for using these technologies? When should traditional approaches be used? How are advanced analytics transforming our ability to make sense of all the data we can now collect? What are regulators asking for and what regulatory guardrails are needed? How are wearables and other digital modalities allowing for diversity in trials and research? What ethical issues must be considered when integrating digital technology?
DIA’s Digital Technology in Clinical Trials Conference will bring together thought leaders from regulatory agencies, biotech, pharma, patients, and academia to discuss the latest advances, challenges, and forward-thinking approaches for implementing digital technology to improve clinical trials. While the conference will focus on the impact of digitalization in clinical trials today, we will make time to explore future applications and how they may enable the clinical trials of tomorrow.
As we work on the 2022 agenda, please take a moment to review the 2021 agenda.
Social distancing measures may be in place at the time of the event. Therefore, we encourageyou to register and make your housing arrangements early due to potential limited capacity. Don’t miss out on your chance to meet live again with your friends and colleagues!
If you are working with digitalization in the clinical trial area I found it very interesting to explore and gain more insights, trends and best practice sharing which will help me to improve our digital strategy
Who should attend?
Professionals involved in: Executive, Leadership, and Management Professionals from Biotechnology, Pharmaceutical, Device, CRO, Regulatory Agency, and Academic Research Sponsors Involved In:
- Business Development
- Clinical Data Management
- Clinical Monitoring and Oversight
- Clinical Operations
- Clinical Site Selection and Management
- Clinical Trials Design and Development
- Contracts Management
- Data Analytics
- Data and Biostatistical Sciences
- Data Strategy
- Data Technology
- Digital Strategies and Technologies
- eClinical Technology and Solutions
- Ethics, IRBs
- Health Economics and Outcomes Research
- Information Technology, Systems, and Programming
- Legal and Compliance
- Medical Affairs
- Medical Communications
- Patient Advocacy, Partnerships, Engagement
- Patient Recruitment and Retention
- Patient Services
- Quality Management
- Regulatory Affairs, Regulatory Specialists
- Research and Development
- Study Endpoint Development
- Security and Privacy Researchers
Megan Doyle, JD, MPH • Global Policy Lead, Digital Health, Diagnostics, Oncology, & Combination Product
Amgen, United States
Jonathan Andrus, MS • President and Chief Operating Officer
Clinical Research IO (CRIO), United States
Rachel Chasse, MS • Digital Operations Lead
Abbvie, United States
Elena Izmailova, PhD • Chief Scientific Officer
Koneksa, United States
Scottie Kern • Executive Director
eCOA Consortium, United Kingdom
Sarah Krug, MS • Chief Executive Officer
CANCER101, United States
Jules Mitchel, PhD, MBA • President and CEO
THI Pharma Services, United States
Steven Murray, PhD • Group Vice President and Principal Engineer, Electrical and Data Sciences
Exponent, United States
Shelly Steele • Senior Scientific Advisor, eCOA
WIRB Med Avante, United States
Keith Wenzel • Senior Director, Scientific Data Organization
Parexel International, United States